Apollomics logo
Apollomics
APLM | NASDAQ
Chart Builder DCF Calculator
$17.84
+$0.16 (+0.90%)
At close: Nov 16, 2026, 4:00 PM ET
$17.51
-$0.33 (-1.85%)
After-hours: Nov 16, 2026, 7:30 PM ET

Apollomics Company Profile

Company profile explained

Company Profile

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.

Key Executives

Name Position
Hung-Wen Chen Chief Executive Officer & Chairman of the Board
K. H. Lin Chief Financial Officer
Yi-Kuei Chen Director & Chief Operating Officer

Latest SEC Filings

Date Type Title
Sep 24, 2026 4/A [Amend] Filing
Sep 24, 2026 4/A [Amend] Filing
Sep 24, 2026 4/A [Amend] Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
View All SEC Filings ➞
Apollomics
Apollomics logo
Country United States
IPO Date Nov 26, 2021
Industry Biotechnology
Sector Healthcare
Employees 14
CEO Hung-Wen Chen

Contact Details

989 East Hillsdale Blvd Foster City, California 94404 United States

Stock Details

Ticker Symbol APLM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001944885
CUSIP Number G0411D123
ISIN Number KYG0411D1236
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.